Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the COVID-19 Pandemic
By Elissa Driggin, Mahesh V. Madhavan, B. Bikdeli, Taylor Chuich, Justin Laracy, G. Biondi‐Zoccai, Tyler S. Brown, Caroline Der Nigoghossian, David A Zidar, J. Haythe and 6 more. Journal of the American College of Cardiology, 2020
1,681 citations recorded by the source corpus.
The coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 that has significant implications for the cardiovascular care of patients. First, those with COVID-19 and pre-existing cardiovascular disease have an increased risk of severe disease and death. Second, infection has been associated with multiple direct and indirect cardiovascular complications including acute myocardial injury, myocarditis, arrhythmias, and venous thromboembolism. Third, therapies under investigation for COVID-19 may have cardiovascular side effects. Fourth, the response to COVID-19 can compromise the rapid triage of non-COVID-19 patients with cardiovascular conditions. Finally, the provision of cardiovascular care may place health care workers in a position of vulnerability as they become hosts or vectors of virus transmission. We hereby review the peer-reviewed and pre-print reports pertaining to cardiovascular considerations related to COVID-19 and highlight gaps in knowledge that require further study pertinent to patients, health care workers, and health systems.
Subfields: Clinical Psychology, Infectious Diseases, Oncology
View Paper: https://www.semanticscholar.org/paper/9fd2fc1e31d25fd9fd7d546ca036b3e2249cb65f
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Infectious Diseases
Citations in the corpus
- COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up (2020, background): “Furthermore, higher troponin levels are associated with severe COVID-19 (5,97).”
- SARS-CoV-2 binds platelet ACE2 to enhance thrombosis in COVID-19 (2020, background): “COVID19 has been linked to a number of critical cardiovascular complications [2, 3], and even individuals without a history of cardiovascular disease are at risk of cardiovascular complications [4].”